As of 2025-07-13, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is 0.07 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -1.6%.
The range of the Relative Valuation is 0.07 - 0.07 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -1.4x - -1.4x | -1.4x |
| Fair Price | 0.07 - 0.07 | 0.07 |
| Upside | -1.6% - -1.6% | -1.6% |
| Date | P/E |
| 2025-07-09 | -1.42 |
| 2025-07-04 | -1.42 |
| 2025-07-03 | -1.22 |
| 2025-06-26 | -1.22 |
| 2025-06-20 | -1.32 |
| 2025-06-13 | -1.32 |
| 2025-06-12 | -1.32 |
| 2025-06-10 | -1.22 |
| 2025-06-03 | -1.22 |
| 2025-06-02 | -1.22 |
| 2025-05-28 | -1.22 |
| 2025-05-21 | -1.42 |
| 2025-05-20 | -1.32 |
| 2025-05-14 | -1.32 |
| 2025-05-09 | -1.42 |
| 2025-05-08 | -1.42 |
| 2025-05-07 | -1.42 |
| 2025-05-06 | -1.53 |
| 2025-05-05 | -1.42 |
| 2025-05-01 | -1.32 |
| 2025-04-29 | -1.22 |
| 2025-04-28 | -1.32 |
| 2025-04-25 | -1.22 |
| 2025-04-23 | -1.22 |
| 2025-04-22 | -1.22 |
| 2025-04-21 | -1.32 |
| 2025-04-16 | -1.42 |
| 2025-04-15 | -1.42 |
| 2025-04-14 | -1.42 |